Home
Conditions
Hypertrophic Cardiomyopathy (HCM)

Clinical trial condition

Hypertrophic Cardiomyopathy (HCM)

Explore clinical trials studying Hypertrophic Cardiomyopathy (HCM). Study availability and eligibility vary by location and protocol.

34 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Hypertrophic Cardiomyopathy (HCM) trial results

Not Yet Recruiting

Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

NCT07408427

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations: Manchester Centre for Genomic Medicine (MCGM) Multiple Locations, United Kingdom

View Trial Details

Not Yet Recruiting

The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

NCT07103655

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations: Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Myocardial Energetic Restoration in the Treatment of Obstructive Hypertrophic Cardiomyopathy

NCT07332767

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population

NCT06775665

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Early Identification and Treatment of Rare Cardiomyopathy Cohorts

NCT06794710

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +15 more
Locations: Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA

NCT06748261

Conditions: Amyloid Cardiomyopathy, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +38 more
Locations: Not specified

View Trial Details

Completed

Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy

NCT07529938

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +9 more
Locations: Fuwai Central China Cardiovascular Hospital Zhengzhou, Henan, China

View Trial Details

Completed

Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy

NCT04219826

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations: Cedar-Sinai Medical Center Los Angeles, California, United States

UCSF Medical Center San Francisco, California, United States

Northwestern University Evanston, Illinois, United States

Tufts Medical Center Boston, Massachusetts, United States

View all 22 locations

View Trial Details

Completed

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy

NCT01623245

Conditions: Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +23 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

NCT00753233

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +11 more
Locations: National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Hypertrophic Cardiomyopathy (HCM)

Hypertrophic Cardiomyopathy (HCM) trial results

Related conditions